New York State Common Retirement Fund
SPRY icon

New York State Common Retirement Fund’s ARS Pharmaceuticals SPRY Stock Holding History

New York State Common Retirement Fund’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Hold
17,707
– – ﹤0.01% 2512
2026
Q1 		$142K Hold
17,707
– – ﹤0.01% 2364
2025
Q4 		$206K Hold
17,707
– – ﹤0.01% 2286
2025
Q3 		$178K Sell
17,707
-75,591
-81% -$1.08M ﹤0.01% 2344
2025
Q2 		$1.63M Buy
93,298
+20,545
+28% +$296K ﹤0.01% 1485
2025
Q1 		$915K Buy
72,753
+36,411
+100% +$438K ﹤0.01% 1670
2024
Q4 		$383K Sell
36,342
-5,361
-13% -$75.1K ﹤0.01% 2030
2024
Q3 		$605K Buy
41,703
+29,596
+244% +$352K ﹤0.01% 1868
2024
Q2 		$103K Buy
12,107
+31
+0.3% +$275 ﹤0.01% 2778
2024
Q1 		$123K Sell
12,076
-36
-0.3% -$268 ﹤0.01% 2654
2023
Q4 		$66.4K Sell
12,112
-41
-0.3% -$180 ﹤0.01% 2913
2023
Q3 		$45.9K Sell
12,153
-3,447
-22% -$22.6K ﹤0.01% 3045
2023
Q2 		$105K Buy
+15,600
New +$104K ﹤0.01% 2789
2022
Q3 		– Sell
-169
Closed -$1K – 3434
2022
Q2 		$1K Sell
169
-11,300
-99% -$39.4K ﹤0.01% 3405
2022
Q1 		$40K Hold
11,469
– – ﹤0.01% 3209
2021
Q4 		$76K Hold
11,469
– – ﹤0.01% 3144
2021
Q3 		$114K Buy
11,469
+60
+0.5% +$1.48K ﹤0.01% 3097
2021
Q2 		$352K Buy
11,409
+3,709
+48% +$119K ﹤0.01% 2776
2021
Q1 		$336K Buy
+7,700
New +$364K ﹤0.01% 2646

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

New York State Common Retirement Fund's SPRY Position: Q2 2026 in Review

New York State Common Retirement Fund held its ARS Pharmaceuticals (SPRY) position steady in Q2 2026 at 17,707 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #2512.

New York State Common Retirement Fund first reported a position in SPRY in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.63M in Q2 2025. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • New York State Common Retirement Fund held 17,707 shares of ARS Pharmaceuticals worth $142K as of Q2 2026.
  • New York State Common Retirement Fund left its ARS Pharmaceuticals share count unchanged in Q2 2026.
  • ARS Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2512 holding.
  • New York State Common Retirement Fund first reported a position in ARS Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • New York State Common Retirement Fund's ARS Pharmaceuticals position peaked at $1.63M in Q2 2025.
  • 209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.